There are indications that the comprehensive reform in the field of medical and health care in China has begun to be gradually implemented.

At the same time, in the field of medical and health care, because of the relationship between interest export and interest synergy, the suspected counterfeiting behavior has become increasingly prominent.

For example, at the end of 221, employees of AstraZeneca, a foreign-funded enterprise in Shenzhen, were investigated for allegedly tampering with and forging the genetic test results of cancer patients.

in view of the fact that the staff of AstraZeneca Pharmaceutical Co., Ltd. were suspected of tampering with the genetic test results of tumor patients to defraud the medical insurance fund, the head of the fund supervision department of the State Medical Insurance Bureau said that in the early stage, according to the clues reported by the masses, the State Medical Insurance Bureau urged Shenzhen to set up a joint task force composed of medical insurance, public security, health and market supervision departments to conduct an in-depth investigation into the case, and all the suspects had been arrested.

According to the news information, it can be known that after Zhang Moumou, the mother of Gao Moumou in tianquan county, Sichuan Province, was diagnosed with lung cancer, in June 219, at the suggestion of doctors in Huaxi Hospital, Gao Moumou began to spend 15,3 yuan per month to buy AstraZeneca's oxitinib for his mother.

One of the conditions for using and reimbursing oxytinib drugs is "adult patients with locally advanced or metastatic non-small cell lung cancer who are confirmed to have EGFR-T79M mutation", and no EGFR-T79M gene mutation was detected in Zhang Moumou in 217 and 218.

In order to reduce the burden of medication, Zhang Moumou obtained a genetic test certificate of "EGFR-T79M gene positive mutation" from others and enjoyed medical insurance reimbursement. Soon after, this genetic test certificate was found to be forged in the investigation of tianquan county Medical Insurance Bureau.

As a result, AstraZeneca, a foreign-funded medical industry in the UK, was found to be suspected of defrauding the national medical insurance fund by illegal means, and the media revealed that public opinion surged on the Internet for a time, criticizing this foreign-funded medical enterprise in China extensively and strongly.